- Home
- VRDN vs MBIN Comparison
VRDN vs MBIN Comparison
Compare VRDN & MBIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- MBIN
- Stock Information
- Founded
- VRDN 2006
- MBIN 1990
- Country
- VRDN United States
- MBIN United States
- Employees
- VRDN N/A
- MBIN 663
- Industry
- VRDN Medical Specialities
- MBIN Major Banks
- Sector
- VRDN Health Care
- MBIN Finance
- Exchange
- VRDN Nasdaq
- MBIN Nasdaq
- Market Cap
- VRDN 1.3B
- MBIN 1.6B
- IPO Year
- VRDN N/A
- MBIN 2017
- Fundamental
- Price
- VRDN $17.28
- MBIN $34.69
- Analyst Decision
- VRDN Strong Buy
- MBIN Buy
- Analyst Count
- VRDN 11
- MBIN 3
- Target Price
- VRDN $38.50
- MBIN $47.50
- AVG Volume (30 Days)
- VRDN 667.1K
- MBIN 221.9K
- Earning Date
- VRDN 08-07-2025
- MBIN 07-28-2025
- Dividend Yield
- VRDN N/A
- MBIN 1.15%
- EPS Growth
- VRDN N/A
- MBIN N/A
- EPS
- VRDN N/A
- MBIN 5.44
- Revenue
- VRDN $302,000.00
- MBIN $621,412,000.00
- Revenue This Year
- VRDN N/A
- MBIN $1.16
- Revenue Next Year
- VRDN $17,102.33
- MBIN $9.35
- P/E Ratio
- VRDN N/A
- MBIN $6.38
- Revenue Growth
- VRDN 4.86
- MBIN 7.58
- 52 Week Low
- VRDN $9.90
- MBIN $27.25
- 52 Week High
- VRDN $27.20
- MBIN $53.27
- Technical
- Relative Strength Index (RSI)
- VRDN 60.64
- MBIN 52.77
- Support Level
- VRDN $16.46
- MBIN $34.49
- Resistance Level
- VRDN $18.44
- MBIN $35.60
- Average True Range (ATR)
- VRDN 0.81
- MBIN 1.19
- MACD
- VRDN 0.04
- MBIN -0.11
- Stochastic Oscillator
- VRDN 57.82
- MBIN 58.95
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About MBIN Merchants Bancorp
Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and the Banking segment, which generates maximum revenue, and provides various financial products and services to consumers and businesses.